As of June 12, 2025, ProQR Therapeutics NV (PRQR) reports a Graham Number of 5.58.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of ProQR Therapeutics NV's Graham Number
Over recent years, ProQR Therapeutics NV's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 5.58 |
| 2023-12-31 | 5.58 |
This trend highlights how ProQR Therapeutics NV manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing ProQR Therapeutics NV's Graham Number to Peers
To better understand ProQR Therapeutics NV's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| ProQR Therapeutics NV (PRQR) | 5.58 |
| argenx SE (ARGX.BR) | 166.26 |
| Uniqure NV (QURE) | 44.74 |
| NextCure Inc (NXTC) | 21.76 |
| XOMA Corp (XOMA) | 19.59 |
| Immunic Inc (IMUX) | 16.88 |
Compared to its competitors, ProQR Therapeutics NV's Graham Number is among the lowest compared to peers, which may indicate relative fundamental weakness by Graham's criteria.